Sustained Immunogenicity of 2-dose Human Papillomavirus 16/18 AS04-adjuvanted Vaccine Schedules in Girls Aged 9-14 Years: A Randomized Trial.
about
Antibody responses among adolescent females receiving two or three quadrivalent human papillomavirus vaccine doses at standard and prolonged intervals.Immune Response to Human Papillomavirus One Year after Prophylactic Vaccination with AS04-Adjuvanted HPV-16/18 Vaccine: HPV-Specific IgG and IgA Antibodies in the Circulation and the Cervix
P2860
Sustained Immunogenicity of 2-dose Human Papillomavirus 16/18 AS04-adjuvanted Vaccine Schedules in Girls Aged 9-14 Years: A Randomized Trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Sustained Immunogenicity of 2- ...... -14 Years: A Randomized Trial.
@en
type
label
Sustained Immunogenicity of 2- ...... -14 Years: A Randomized Trial.
@en
prefLabel
Sustained Immunogenicity of 2- ...... -14 Years: A Randomized Trial.
@en
P2093
P2860
P50
P356
P1476
Sustained Immunogenicity of 2- ...... 9-14 Years: A Randomized Trial
@en
P2093
Angelo Pellegrino
Carlo Giaquinto
Chiu Cheng-Hsun
Damien Friel
Dominique Descamps
Florence Thomas
Karl Ulrich Petry
Klaus Peters
Louise Frenette
Marjan Hezareh
P2860
P304
P356
10.1093/INFDIS/JIX154
P407
P577
2017-06-01T00:00:00Z